Closing the Critical Care Gap: Making Hypoglycemia Readiness Routine

Overview

Severe Hypoglycemia remains one of the most serious risks for people living with diabetes. One severe event can have devastating consequences. Yet despite clinical practice guidelines, ready-to-use glucagon remains underprescribed and underutilized. Join Xeris Pharmaceuticals® for an eye-opening session that shines a light on the millions of at-risk patients who don’t have this essential treatment for severe hypoglycemia.

You’ll discover:
oWho is at risk
oWhat current clinical guidelines recommend and why experts are calling for urgent action
oHow ready-to-use glucagon is transforming rescue readiness
o Practical tips to identify at-risk patients and integrate routine prescribing into your practice workflow

Let’s close the critical care gap so every person at risk is equipped to respond when it matters most—and ensure your practice is aligned with the current standards of care.